Ghana has rejected a $109 million United States health deal after determining that its terms required the country to trade away legal safeguards on data, bypass its own parliament, and accept conditions that did not align with its laws.
Development Diaries reports that after months of negotiations that began in November 2025, the United States set a 24 April, 2026, deadline for Ghana to sign the agreement under its America First Global Health Strategy.
But when that deadline passed without a signature, officials in Accra chose to walk away after reviewing the terms against domestic legal requirements.
The agreement required Ghana to share sensitive national health data, suspend protections under its Data Protection and Public Health laws, and proceed without parliamentary ratification, which is a constitutional requirement for bilateral agreements.
Ghana’s decision stands out because several African countries had already signed similar agreements, including Nigeria, Uganda, Rwanda, Lesotho, eSwatini, Mozambique, Cameroon, and Ethiopia, while Kenya’s $1 billion deal signed in December 2025 was suspended by a High Court in April 2026 after legal challenges over data privacy and sovereignty concerns.
The shift in approach follows the dismantling of the United States Agency for International Development (USAID) in 2025, which removed a long-standing multilateral funding structure and replaced it with direct bilateral agreements that transfer greater financial responsibility to African governments while introducing new conditions around data access.
Under this framework, participating countries are required to share pathogen and health surveillance data, including information on disease outbreaks, without guaranteed access to the medical innovations that may be developed from that data.
The pattern reflects a broader structural issue in which African countries are negotiating individually without a coordinated position from the African Union, leaving each government to engage separately in agreements that have continental implications for data governance and health systems.
Responsibility for the outcome sits across multiple actors, as the United States designed a bilateral framework that favours one-on-one negotiations, African governments that signed without parliamentary scrutiny accepted terms without a full constitutional process, and the AU has not established a shared negotiating framework or minimum standards for member states.
The issue extends beyond funding arrangements into questions of rights and governance, as health data falls within existing legal protections in countries such as Ghana and Kenya, and agreements that enable access to that data without legislative oversight raise concerns about consent, transparency, and accountability in public policy decisions.
The impact of these agreements is not evenly distributed, as communities that rely on externally supported health services, particularly rural populations and women dependent on maternal and HIV-related care, face the greatest risk when funding structures shift or decline under new conditions.
Countries that have resisted similar agreements are already facing consequences, with Zimbabwe experiencing reductions in United States health assistance and others, such as South Africa and Zambia, confronting funding gaps without a clearly defined replacement structure.
Public health experts have framed the issue as one of structural imbalance, noting that Africa generates a significant share of global communicable disease data while retaining limited control over the pharmaceutical and research systems that use that data.
The development places Ghana at the centre of a broader continental question about how African governments negotiate external partnerships, whether through individual agreements shaped by immediate needs or through coordinated positions that reflect shared interests and long-term policy considerations.
